Literature DB >> 19038339

Tolerance versus immune response -- microRNAs as important elements in the regulation of the HLA-G gene expression.

T D Veit1, J A B Chies.   

Abstract

HLA-G is a class Ib HLA which has gained much attention due to its multiple functions on the immune system. HLA-G exerts several immunomodulatory effects, being beneficially implicated in embryo implantation and fetal survival but, conversely, being potentially detrimental in tumors and viral infections. Such a two-edged sword behavior suggest that HLA-G expression is under tight regulation. However, to date, little is known about the regulation of this gene and previous works have been unable to well correlate HLA-G regulation at the mRNA level with the polymorphic variants at the genomic level. Here we present the hypothesis that an element, which was until now neglected, might play a role in HLA-G expression regulation: MicroRNAs might participate in the regulation of the HLA-G gene expression through a putative microRNA binding site at its 3' UTR region. Inside the 20 nt region of this microRNA binding site lies a C/G polymorphism, which was shown to be responsible for differential microRNA binding affinity and translation suppression. The role of microRNA binding on the regulation of HLA-G gene expression (and therefore on tolerance versus immune response) can be easily tested through relatively simple steps: Confirming the expression of those three complementary microRNAs in human cells which express HLA-G, followed by examination of the correlation between HLA-G mRNA and protein production controlling for HLA-G genotypes and microRNA levels; finally, selective inhibition of microRNA activity with anti-sense oligos restoring HLA-G production would access microRNA influence on HLA-G expression which, if confirmed, might help in the development of strategies to the management of several conditions in which HLA-G is involved, including pregnancy complications, transplantation, and cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19038339     DOI: 10.1016/j.trim.2008.11.001

Source DB:  PubMed          Journal:  Transpl Immunol        ISSN: 0966-3274            Impact factor:   1.708


  36 in total

Review 1.  Nanoparticles targeting HLA-G for gene therapy in cancer.

Authors:  Ines Zidi; Nidhal Ben Amor
Journal:  Med Oncol       Date:  2011-04-17       Impact factor: 3.064

2.  Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Christine Stoehr; Juergen Bukur; Chiara Massa; Juliane Braun; Stefan Hüttelmaier; Verena Spath; Roland Wartenberg; Wolfgang Legal; Helge Taubert; Sven Wach; Bernd Wullich; Arndt Hartmann; Barbara Seliger
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

3.  Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.

Authors:  Inès Zidi; Olfa Dziri; Nour Zidi; Refaat Sebai; Nadia Boujelebene; Amna Ben Hassine; Hamza Ben Yahia; Ahmed Baligh Laaribi; Wafa Babay; Hela Rifi; Amel Mezlini; Hanene Chelbi
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

4.  Human Parthenogenetic Embryonic Stem Cell-Derived Neural Stem Cells Express HLA-G and Show Unique Resistance to NK Cell-Mediated Killing.

Authors:  Jessica Schmitt; Sigrid Eckardt; Paul G Schlegel; Anna-Leena Sirén; Valentin S Bruttel; K John McLaughlin; Jörg Wischhusen; Albrecht M Müller
Journal:  Mol Med       Date:  2015-03-23       Impact factor: 6.354

5.  Impact of HLA-G polymorphism on the outcome of allogeneic hematopoietic stem cell transplantation for metastatic renal cell carcinoma.

Authors:  R Crocchiolo; O Ringden; J-O Bay; D Blaise; B Omasic; B Mazzi; C Picard; S Trinca; L Barkholt; J Peccatori; S Gregori; G Amodio; K Fleischhauer; F Ciceri; M Bregni
Journal:  Bone Marrow Transplant       Date:  2017-11-13       Impact factor: 5.483

6.  Maternal human leukocyte antigen-G (HLA-G) genetic variants associate with in utero mother-to-child transmission of HIV-1 in Black South Africans.

Authors:  Heather A Hong; Maria Paximadis; Glenda E Gray; Louise Kuhn; Caroline T Tiemessen
Journal:  Infect Genet Evol       Date:  2014-12-23       Impact factor: 3.342

Review 7.  Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?

Authors:  Laurence Amiot; Soldano Ferrone; Hans Grosse-Wilde; Barbara Seliger
Journal:  Cell Mol Life Sci       Date:  2010-11-10       Impact factor: 9.261

8.  Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.

Authors:  Tao Li; Haohai Huang; Dan Liao; Huahuang Ling; Bingguang Su; Maode Cai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

Review 9.  Cancer and pregnancy: parallels in growth, invasion, and immune modulation and implications for cancer therapeutic agents.

Authors:  Shernan G Holtan; Douglas J Creedon; Paul Haluska; Svetomir N Markovic
Journal:  Mayo Clin Proc       Date:  2009-11       Impact factor: 7.616

Review 10.  HLA-G: a human pregnancy-related immunomodulator.

Authors:  Joan S Hunt; Daudi L Langat
Journal:  Curr Opin Pharmacol       Date:  2009-06-29       Impact factor: 5.547

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.